Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04194541 · ClinicalTrials.gov registry record · NA
Wound Dressings for Hidradenitis Suppurativa
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04194541 is a NA study that has completed, run by University of Miami. The registered enrollment target is 28 participants.
The verdict
NCT04194541, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The primary purpose of this research is to determine how the types of wound dressings affect quality of life for people with Hidradenitis Suppurativa (HS).
Interventions
- DEVICE Cutimed Sorbact Hydroactive B wound dressing
- DEVICE Cutimed Siltect wound dressing
- DEVICE Sorbion Sana multi-star wound dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2020-01-28 |
| Est. Completion | 2021-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04194541
The ClinicalTrials.gov registry entry for NCT04194541 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cutimed Sorbact Hydroactive B wound dressing is the first listed.
NCT04194541 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04194541 about?
NCT04194541 is a clinical study titled "Wound Dressings for Hidradenitis Suppurativa". The primary purpose of this research is to determine how the types of wound dressings affect quality of life for people with Hidradenitis Suppurativa (HS).
What is the current status of trial NCT04194541?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2020-01-28. Estimated completion is 2021-03-08.
What interventions are being tested in trial NCT04194541?
The interventions under investigation include: Cutimed Sorbact Hydroactive B wound dressing (DEVICE), Cutimed Siltect wound dressing (DEVICE), Sorbion Sana multi-star wound dressing (DEVICE).
Who is sponsoring clinical trial NCT04194541?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.